Reproductive System Neoplasm, Male - Prostate Cancer
NCT01949337
Clinical Trial Information
Trial Number: NCT01949337 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
Phase III Trial of Enzalutamide (NSC# 766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer
Study ID:
A031201
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01949337-D4 | This dataset contains enzalutamide-based PK data which can be input into Pumas PK software to produce final PK results. Three other datasets for PMID 36996380 contain baseline characteristics, outcome data, adverse events, and additional PK data. |
| NCT01949337-D3 | This dataset contains abiraterone based PK data that can be input into Pumas PK software to produce PK results. Three other datasets for PMID 36996380 contain baseline characteristics, outcome data, adverse events, and additional PK data. |
| NCT01949337-D2 | This dataset contains data for adverse event analyses and tables. Three other datasets for PMID 36996380 contain baseline characteristics, outcome data, and PK data. |
| NCT01949337-D1 | This dataset contains data for the baseline characteristics table, primary analysis and secondary analyses minus adverse event and PK analyses. Three other datasets for PMID 36996380 contain adverse event and PK data. |
NCT00063882
Clinical Trial Information
Trial Number: NCT00063882 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
A PHASE III STUDY COMPARING COMBINED EXTERNAL BEAM RADIATION AND TRANSPERINEAL INTERSTITIAL PERMANENT BRACHYTHERAPY WITH BRACHYTHERAPY ALONE FOR SELECTED PATIENTS WITH INTERMEDIATE RISK PROSTATIC CARCINOMA
Study ID:
RTOG-0232
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
NCT00567580
Clinical Trial Information
Trial Number: NCT00567580 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
A PHASE III TRIAL OF SHORT TERM ANDROGEN DEPRIVATION WITH PELVIC LYMPH NODE OR PROSTATE BED ONLY RADIOTHERAPY (SPPORT) IN PROSTATE CANCER PATIENTS WITH A RISING PSA AFTER RADICAL PROSTATECTOMY
Study ID:
RTOG-0534
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00567580-D4 | This dataset, NCT00567580-D4, contains the late adverse event data presented in the RTOG-0534 primary publication (PMID: 35569466). NCT00567580-D1 contains outcome data. NCT00567580-D2 contains highest-grade adverse events. NCT00567580-D3 contains acute adverse events. |
| NCT00567580-D3 | This dataset, NCT00567580-D3, contains the acute adverse event data presented in the RTOG-0534 primary publication (PMID: 35569466). NCT00567580-D1 contains outcome data. NCT00567580-D2 contains highest-grade adverse events. NCT00567580-D4 contains late adverse events. |
| NCT00567580-D2 | This dataset, NCT00567580-D2, contains the highest-grade adverse event data presented in the RTOG-0534 primary publication (PMID: 35569466). NCT00567580-D1 contains outcome data. NCT00567580-D3 contains acute adverse events. NCT00567580-D4 contains late adverse events. |
| NCT00567580-D1 | NCT00567580-D1: This dataset, NCT00567580-D1, contains the patient characteristics, outcome, and toxicity data presented in the RTOG-0534 primary publication (PMID: 35569466). NCT00567580-D2 contains highest-grade adverse events. NCT00567580-D3 contains acute adverse events. NCT00567580-D4 contains late adverse events. |
NCT01809691
Clinical Trial Information
Trial Number: NCT01809691 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
Study ID:
S1216
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01809691-D2 | There are two dataset submissions associated with this publication: NCT01809691-D1 and NCT01809691-D2. These datasets contain the results reported in the Journal of Clinical Oncology (Agarwal et al., Journal of Clinical Oncology, 2022). This toxicity dataset contains event-level information (one row per patient per adverse event experienced on trial). |
| NCT01809691-D1 | There are two dataset submissions associated with this publication: NCT01809691-D1 and NCT01809691-D2. These datasets contain the results reported in the Journal of Clinical Oncology (Agarwal et al., Journal of Clinical Oncology, 2022). This clinical dataset contains patient-level data (one row per patient), including eligibility, evaluability, treatment, demographic, and baseline information. It also contains assessment data. |
NCT00002597
Clinical Trial Information
Trial Number: NCT00002597 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
A Phase III Trial of the Study of Endocrine Therapy used as a Cytoreductive and Cytostatic Agent Prior to Radiation Therapy in Good Prognosis Locally Confined Adenocarcinoma of the Prostate
Study ID:
RTOG-94-08
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
NCT03103321
Clinical Trial Information
Trial Number: NCT03103321 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men
Study ID:
A191402CD
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT03103321-D1 | Dataset NCT03103321-D1-Dataset.csv (manu_data) is one datasets associated with PubMed ID 34890060. This dataset contains data presented in the Consort Diagram, Figure 1, Figure 2, Table 1, Table 2, and Table 3. In order to protect the confidentiality of patients enrolled onto A191402CD, information regarding enrolling sites has been removed from the dataset. |
NCT00430183
Clinical Trial Information
Trial Number: NCT00430183 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
Study ID:
CALGB-90203
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00430183-D2 | Dataset NCT00430183-D2-Dataset.csv (toxicity) is one of 2 datasets associated with PubMed ID 32706639. This dataset contains toxicity information that is presented in the manuscript. |
| NCT00430183-D1 | Dataset NCT00430183-D1-Dataset.csv (baseline) is one of 2 datasets associated with PubMed ID 32706639. This dataset contains information that is presented in the manuscript excluding the toxicity data. |
NCT01238172
Clinical Trial Information
Trial Number: NCT01238172 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
Study ID:
CALGB-70807
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01238172-D5 | Dataset NCT01238172-D5-Dataset.csv (dietcomposition) is one of 5 datasets associated with PubMed ID 31935026. This dataset contains information for the dietary patterns analysis including Table 2 and the eTable. |
| NCT01238172-D4 | Dataset NCT01238172-D4-Dataset.csv (offtreat) is one of 5 datasets associated with PubMed ID 31935026. This dataset contains information for patient off treatment reasons. |
| NCT01238172-D3 | Dataset NCT01238172-D3-Dataset.csv (figout) is one of 5 datasets associated with PubMed ID 31935026. This dataset contains information for the primary analysis. |
| NCT01238172-D2 | Dataset NCT01238172-D2-Dataset.csv (consort_out) is one of 5 datasets associated with PubMed ID 31935026. This dataset contains information for the consort diagram. |
| NCT01238172-D1 | Dataset NCT01238172-D1-Dataset.csv (baseline) is one of 5 datasets associated with PubMed ID 31935026. This dataset contains information for the baseline characteristics table. |
NCT00288080
Clinical Trial Information
Trial Number: NCT00288080 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
A Phase III Protocol of Androgen Suppression (AS) and 3DCRT/IMRT Vs AS and 3DCTR/IMRT Followed by Chemotherapy With Docetaxel and Prednisone for Localized, High-Risk, Prostate Cancer
Study ID:
RTOG-0521
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00288080-D1 | This dataset, NCT00288080-D1, contains the data presented in the RTOG-0521 primary publication (PMID: 30860948). |
NCT00134056
Clinical Trial Information
Trial Number: NCT00134056 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
Phase III Study of Docetaxel and Atrasentan Versus Docetaxel and Placebo for Patients With Advanced Hormone Refractory Prostate Cancer
Study ID:
S0421
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00134056-D1 | This dataset contains quality of life (QOL) data from trial NCT00134056 to reproduce the results reported in the Journal of Patient-Reported Outcomes (Unger et al, JPRO, 2018, PMID29951640). |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®